These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 27659287

  • 1. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL, Francis KE, Lowe DK, Cahoon WD.
    Ther Adv Cardiovasc Dis; 2016 Dec; 10(6):348-352. PubMed ID: 27659287
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
    Verrier RL, Sobrado MF, Pagotto VP, Kanas AF, Machado AD, Varone BB, Sobrado LF, Nearing BD, Zeng D, Belardinelli L.
    Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296
    [Abstract] [Full Text] [Related]

  • 3. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
    Wongcharoen W, Ruttanaphol A, Gunaparn S, Phrommintikul A.
    Int J Cardiol; 2016 Dec 01; 224():252-255. PubMed ID: 27661415
    [Abstract] [Full Text] [Related]

  • 4. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D, Borer JS.
    Drugs; 2007 Dec 01; 67 Suppl 2():15-24. PubMed ID: 17999560
    [Abstract] [Full Text] [Related]

  • 5. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.
    Verrier RL, Bonatti R, Silva AF, Batatinha JA, Nearing BD, Liu G, Rajamani S, Zeng D, Belardinelli L.
    Heart Rhythm; 2014 Dec 01; 11(12):2288-96. PubMed ID: 25111327
    [Abstract] [Full Text] [Related]

  • 6. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L, Simonsen U, Grimm D, Hedegaard ER.
    Basic Clin Pharmacol Toxicol; 2017 Aug 01; 121(2):89-97. PubMed ID: 28371247
    [Abstract] [Full Text] [Related]

  • 7. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K.
    Clin Res Cardiol; 2011 Oct 01; 100(10):915-23. PubMed ID: 21638157
    [Abstract] [Full Text] [Related]

  • 8. Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation.
    Li YD, Ji YT, Zhou XH, Jiang T, Hong YF, Li JX, Xing Q, Xiong J, Yusufuaji Y, Tang BP.
    Med Sci Monit; 2015 May 16; 21():1414-20. PubMed ID: 25982136
    [Abstract] [Full Text] [Related]

  • 9. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J.
    Methods Find Exp Clin Pharmacol; 2008 Oct 16; 30(8):633-41. PubMed ID: 19088948
    [Abstract] [Full Text] [Related]

  • 10. Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular Disease.
    Nawarskas JJ, Bowman BN, Anderson JR.
    Cardiol Rev; 2015 Oct 16; 23(4):201-11. PubMed ID: 25839989
    [Abstract] [Full Text] [Related]

  • 11. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.
    Verrier RL, Silva AF, Bonatti R, Batatinha JA, Nearing BD, Liu G, Rajamani S, Zeng D, Belardinelli L.
    J Cardiovasc Electrophysiol; 2015 Mar 16; 26(3):329-35. PubMed ID: 25346368
    [Abstract] [Full Text] [Related]

  • 12. Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.
    Wang J, Yang YM, Li Y, Zhu J, Lian H, Shao XH, Zhang H, Fu YC, Zhang LF.
    J Cardiovasc Electrophysiol; 2019 Feb 16; 30(2):242-252. PubMed ID: 30302853
    [Abstract] [Full Text] [Related]

  • 13. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 14. Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project.
    Fontenla A, López-Gil M, Tamargo-Menéndez J, Matía-Francés R, Salgado-Aranda R, Rey-Blas JR, Miracle-Blanco Á, Mejía-Martínez E, Pastor-Fuentes A, Toquero-Ramos J, Arias MÁ, Montilla I, Gómez de la Cámara A, Arribas F, BRAKE-AF investigators.
    Rev Esp Cardiol (Engl Ed); 2020 May 01; 73(5):368-375. PubMed ID: 31631048
    [Abstract] [Full Text] [Related]

  • 15. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 16. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N, Bhargava B.
    Am J Cardiovasc Drugs; 2011 Oct 27; 11(1):1-12. PubMed ID: 21090826
    [Abstract] [Full Text] [Related]

  • 17. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U, Stöckl G, Werdan K.
    Vasc Health Risk Manag; 2016 Oct 27; 12():453-470. PubMed ID: 27895488
    [Abstract] [Full Text] [Related]

  • 18. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
    Cardiol J; 2015 Oct 27; 22(2):227-32. PubMed ID: 25179314
    [Abstract] [Full Text] [Related]

  • 19. Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets.
    Koncz I, Szél T, Jaeger K, Baczkó I, Cerbai E, Romanelli MN, Gy Papp J, Varró A.
    Curr Med Chem; 2011 Oct 27; 18(24):3662-74. PubMed ID: 21774761
    [Abstract] [Full Text] [Related]

  • 20. Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial.
    Fontenla A, Tamargo J, Salgado R, López-Gil M, Mejía E, Matía R, Toquero J, Montilla I, Rajjoub EA, García-Fernandez FJ, Miracle A, Rey JR, Bueno H, BRAKE-AF Study Investigators.
    Heart Rhythm; 2023 Jun 27; 20(6):822-830. PubMed ID: 37245897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.